Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD)

Belicchi, M

Bresolin, N

Cattaneo, A

Cossu, G

D'Angelo, MG

Farini, A

Gavina, M

Marchesi, C

Meregalli, M

Parolini, D

Porretti, L

Torrente, Y

PLoS ONE

PubMed

Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD).The levels of several subpopulations of circulating stem cells expressing the CD133 antigen were determined by flow cytometry in 70 DMD patients. The correlation between the levels and clinical status was assessed by statistical analysis. The median (+/-SD) age of the population was 10.66+/-3.81 (range 3 to 20 years). The levels of CD133+CXCR4+CD34- stem cells were significantly higher in DMD patients compared to healthy controls (mean+/-standard deviation: 17.38+/-1.38 vs. 11.0+/-1.70; P = 0.03) with a tendency towards decreased levels in older patients. Moreover, the levels of this subpopulation of cells correlated with the clinical condition. In a subgroup of 19 DMD patients after 24 months of follow-up, increased levels of CD133+CXCR4+CD34- cells was shown to be associated with a phenotype characterised by slower disease progression. The circulating CD133+CXCR4+CD34- cells in patients from different ages did not exhibit significant differences in their myogenic and endothelial in vitro differentiation capacity.Our results suggest that levels of CD133+CXCR4+CD34- could function as a new prognostic clinical marker for the progression of DMD

Chiara Marchesi

Marzia Belicchi

Mirella Meregalli

Andrea Farini

Alessandra Cattaneo

Daniele Parolini

Manuela Gavina

Laura Porretti

Maria Grazia D'Angelo

Nereo Bresolin

Giulio Cossu

Yvan Torrente

Directory of Open Access Journals

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients.

UCL Discovery

Background: Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD). Methods and Findings: The levels of several subpopulations of circulating stem cells expressing the CD133 antigen were determined by flow cytometry in 70 DMD patients. The correlation between the levels and clinical status was assessed by statistical analysis. The median (+/- SD) age of the population was 10.66 +/- 3.81 (range 3 to 20 years). The levels of CD133+CXCR4+CD34- stem cells were significantly higher in DMD patients compared to healthy controls (mean +/- standard deviation: 17.38 +/- 1.38 vs. 11.0 +/- 1.70; P = 0.03) with a tendency towards decreased levels in older patients. Moreover, the levels of this subpopulation of cells correlated with the clinical condition. In a subgroup of 19 DMD patients after 24 months of follow-up, increased levels of CD133+CXCR4+CD34- cells was shown to be associated with a phenotype characterised by slower disease progression. The circulating CD133+CXCR4+CD34- cells in patients from different ages did not exhibit significant differences in their myogenic and endothelial in vitro differentiation capacity. Conclusions: Our results suggest that levels of CD133+CXCR4+CD34- could function as a new prognostic clinical marker for the progression of DMD

C. Marchesi

M. Belicchi

M. Meregalli

A. Farini

A. Cattaneo

D. Parolini

M. Gavina

N. Bresolin

G.  Cossu

Y. Torrente

L. Porretti

M. G. D'Angelo

AIR Universita degli studi di Milano

Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients

A novel fivetransmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS).

Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy.

Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.

Circulating endothelial cells in cardiovascular disease.

Circulating endothelial progenitor cells and cardiovascular outcomes.

Circulating progenitor cells are reduced in patients with severe lung disease.

Duchenne muscular dystrophy: patterns of clinical progression and effect of supportive therapy.

Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Effects of glucocorticoids and mineralcorticoids on proliferation and maturation of human peripheral bllod stem cells.

Ferlini A

Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes.

Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle.

Identification and clinical significance of circulating endothelial progenitor cells in human nonsmall cell lung cancer.

Isolation and characterization of human CD34(2)Lin(2) and CD34(+)Lin(2) hematopoietic stem cells using cell surface markers AC133 and CD7.

Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy.

Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool.

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis.

Mechanisms of resistance to pathogenesis in muscular dystrophies.

Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies.

Prediction of coronary heart disease using risk factor categories.

Prognostic factors in mild dystophinopathies.

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy.

Survival in Duchenne muscular dystrophy: improvements in life expectancy since

The association of c-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population.

The heart in human dystrophinopathies.

The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease.

VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation.

https://air.unimi.it/retrieve/handle/2434/61427/144097/journal.pone.0002218%5b1%5d.pdf

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients.

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

UCL Discovery

AIR Universita degli studi di Milano